About
Cell therapy to treat mitochondrial diseases
Areas of Focus
Categories
Stem Cell & Cellular TherapyMiddle East
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
528
By Phase
PHASE1: 2PHASE2: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 4ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1COMPLETED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06465160Lead Sponsor
A Study to Evaluate the MNV-201 in Patients With Low Risk MDS
PHASE1Recruiting
15 participants
Started: May 27, 2024 · Completed: Dec 31, 2029
NCT06474104Lead Sponsor
Collection of Blood and Skin Samples From Patients With Primary Mitochondrial Diseases and Healthy Volunteers
N/ARecruiting
100 participants
Started: May 12, 2024 · Completed: May 30, 2027
NCT06017869Lead Sponsor
Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)
PHASE2Recruiting
6 participants
Started: Jul 31, 2023 · Completed: Dec 31, 2027
NCT06144515Lead Sponsor
Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome
N/AActive, not recruiting
100 participants
Started: Feb 9, 2023 · Completed: Mar 1, 2026
NCT04548843Lead Sponsor
A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion
PHASE1Withdrawn
Started: Mar 1, 2022 · Completed: Dec 1, 2024
Locations (1)
Headquarters
Tirat Hacarmel, Israel
Map
Loading map...